Issue NEWS-2026-W41-p4 · Oct 5, 2026 to Oct 11, 2026

The Daily Trickle

Plain words, straight from the source. Every item links to the original document. No news outlets, no hot takes.

This week, from source to page

1540 documents from primary sources, published this week
40 selected passed the news gate
40 in this issue passed the fact check

Health and drugs

Peer-reviewed studyPLOS Medicine

New aging index predicts mortality risk in cardiovascular-kidney-metabolic syndrome

A peer-reviewed retrospective cohort study published October 6, 2026, followed 6,896 adults from the National Health and Nutrition Examination Survey (NHANES), 2005-2018, to test a machine learning aging index for predicting death in cardiovascular-kidney-metabolic (CKM) syndrome. The authors report that the index outperformed comparison indices for all-cause and cardiovascular mortality, and that depression partly explained these links. The study is observational, shows associations rather than cause, and was not validated in cohorts from other geographic regions.

Published
Oct 6, 2026
DOI 10.1371/journal.pmed.1005078
Preprint, not peer-reviewedbioRxiv

Lab study finds complement proteins block antibody binding in immune cells

A preprint, not yet reviewed by other scientists, published October 7, 2026, reports laboratory experiments on human neutrophils, immune cells that engulf bacteria. The authors report that when complement is present, blocking antibody receptors no longer changes bacterial uptake, and that the protein C1q physically hinders contact between antibodies and those receptors. They say this matters for therapeutic antibody development.

Published
Oct 7, 2026
DOI 10.64898/2026.09.30.755584
Preprint, not peer-reviewedbioRxiv

Mouse study maps lung immune cells linked to tuberculosis protection

A preprint, not yet reviewed by other scientists, published October 7, 2026, profiles immune cells in the lungs of male and female mice after tuberculosis (TB) infection and after vaccination with Bacille Calmette-Guerin (BCG) or a live attenuated vaccine. The authors identify Thy1.2 expression on natural killer (NK) cells as a candidate sex-specific marker of protection, and say the study shows that sex matters in rodent models of tuberculosis.

Published
Oct 7, 2026
DOI 10.64898/2026.09.30.755733
Preprint, not peer-reviewedmedRxiv

Voice features may track depression, early preprint finds

A preprint, not yet reviewed by other scientists, published October 7, 2026, examines whether voice-quality features of speech, such as shimmer and harmonics-to-noise ratio (HNR), distinguish adults with depression from healthy controls and track symptom scores during treatment. The cross-sectional comparison included 82 adults with depressive disorders and 80 healthy controls, and the authors report that voice features were the most consistent speech correlates across analyses. They say the modest samples and chart-based diagnoses mean these features cannot yet be recommended as clinical tests.

Published
Oct 7, 2026
DOI 10.64898/2026.10.05.26364692
Preprint, not peer-reviewedmedRxiv

Study links digital supply systems to better drug availability in Ethiopia

A preprint, not yet reviewed by other scientists, published October 7, 2026, analyzes a 2024/2025 national survey of 1245 public health facilities in Ethiopia, looking at use of the electronic Logistics Management Information System (eLMIS) and Auditable Pharmaceutical Transactions and Services (APTS). The authors report that 54.2% of facilities had optimal availability of essential commodities, and an adjusted odds ratio of 4.32 for facilities using both systems. It is a secondary analysis of survey data, so the link is an association rather than proof that the systems cause better supply.

Published
Oct 7, 2026
DOI 10.64898/2026.10.05.26364822
Preprint, not peer-reviewedbioRxiv

Structures show how cardiac potassium channels assemble and respond to drugs

A preprint, not yet reviewed by other scientists, published October 7, 2026, reports high-resolution structures of G protein-gated inwardly rectifying potassium (GIRK) channels in the heart, which form in unexpected subunit ratios. The authors report that adding GIRK1 subunits progressively opens the channel, and that the drug ML297 inhibits one arrangement while potentiating another. This is basic laboratory research aimed at designing more selective drugs.

Published
Oct 7, 2026
DOI 10.64898/2026.10.06.756879
Preprint, not peer-reviewedChemRxiv

Lab study shows copper binds glucagon hormones, relevant to diabetes

A preprint, not yet reviewed by other scientists, published October 8, 2026, reports spectroscopy experiments showing that glucagon and glucagon-like peptide 1 (GLP1) bind copper in ways that depend on the copper-to-hormone ratio. The authors say the diabetes drug metformin, a first-line treatment for Type 2 diabetes, can deliver copper to these hormones. The work is laboratory-only and does not measure effects in patients.

Published
Oct 8, 2026
DOI 10.26434/chemrxiv.15010094/v1
Preprint, not peer-reviewedbioRxiv

Study identifies gut microbe enzymes that turn cholesterol into coprostanol

A preprint, not yet reviewed by other scientists, published October 8, 2026, identifies an enzyme called SpiE that, working with SpiR, converts cholesterol into coprostanol, a sterol largely excreted in feces. In patient cohorts followed over time, antibiotic treatment coincided with loss of the enzyme and of coprostanol production, which recovered in some individuals as other SpiE-carrying genera emerged. The authors say the work lays groundwork for studies linking this pathway to host physiology.

Published
Oct 8, 2026
DOI 10.64898/2026.10.06.757028
Preprint, not peer-reviewedbioRxiv

Engineered protein reactivates latent HIV in lab and animal tests

A preprint, not yet reviewed by other scientists, published October 8, 2026, describes an engineered bispecific biologic that delivers interleukin-15 (IL-15) signaling to memory CD4 T cells to reactivate latent human immunodeficiency virus type 1 (HIV-1). The authors report reactivation in 94% (48/51) of clinical samples ex vivo, in 75% (15/20) of administrations in humanized mice on antiretroviral therapy (ART), and in 100% (6/6) of simian immunodeficiency virus (SIV)-infected macaques at well-tolerated doses. The study is preclinical, and the authors say it could complement other reservoir-elimination strategies.

Published
Oct 8, 2026
DOI 10.64898/2026.10.06.757104
Preprint, not peer-reviewedmedRxiv

Most women have heavy or painful periods at some point, cohort study finds

A preprint, not yet reviewed by other scientists, published October 9, 2026, pools six longitudinal population-based cohorts from the United Kingdom, United States, Norway and Australia to estimate how often heavy menstrual bleeding (HMB) and menstrual pain (MP) are reported across life. The authors report cumulative prevalence of 36% to 89% for heavy bleeding and 46% to 72% for pain, with pain more common in adolescence and heavy bleeding more common at ages 45 and above.

Published
Oct 9, 2026
DOI 10.64898/2026.10.07.26364868
Preprint, not peer-reviewedmedRxiv

Genetic study finds no robust causal link between COVID-19 and heart attack

A preprint, not yet reviewed by other scientists, published October 9, 2026, uses Mendelian randomization, a genetic method, across European, East Asian, South Asian and African populations to test whether COVID-19 causally affects acute myocardial infarction (AMI). The authors report slight, non-significant inverse associations for severe and hospitalized COVID-19 in European ancestry, and no significant associations in East Asian or African ancestry. They conclude the cardiovascular burden may be driven more by acute mechanisms than by shared genetics.

Published
Oct 9, 2026
DOI 10.64898/2026.10.07.26364920
Preprint, not peer-reviewedmedRxiv

Study finds child maltreatment acceptability varies across 13 countries and regions

A preprint, not yet reviewed by other scientists, published October 9, 2026, reports an online survey of 1,617 adults across 13 countries and regions on self-reported child maltreatment and how acceptable they perceive it to be. Greater exposure was linked to poorer mental health for several types and to greater acceptability of maltreatment, while prevalence and acceptability varied by place. The authors call for culturally sensitive assessment and intervention.

Published
Oct 9, 2026
DOI 10.64898/2026.10.07.26364967
Preprint, not peer-reviewedmedRxiv

Benchmark finds AI answers often miss matching patient-specific evidence

A preprint, not yet reviewed by other scientists, published October 9, 2026, introduces Precision Evidence Bench, a set of 209 synthetic clinical questions with specified population, intervention, comparator and outcome elements. The authors tested four large language models with web search, and report that precision match rates rose from 13 to 18% with web search alone to 41 to 56% with access to 500 million precision evidence findings.

Published
Oct 9, 2026
DOI 10.64898/2026.10.07.26364976
Preprint, not peer-reviewedmedRxiv

Vitamin D levels adjusted for season track death risk in UK Biobank

A preprint, not yet reviewed by other scientists, published October 9, 2026, analyzes 412,020 UK Biobank participants, standardizing vitamin D measurements to a common late-winter level and reporting 31,197 deaths. The authors report a mortality hazard ratio of 2.03 for vitamin D below 5 ng/mL compared with 20 ng/mL or above, and say the findings reproduce links to diabetes, dementia and other conditions seen in earlier cohorts. The authors argue for a causal interpretation, but the study is observational.

Published
Oct 9, 2026
DOI 10.64898/2026.10.07.26364983
Preprint, not peer-reviewedmedRxiv

Part-time work, not retirement timing, linked to dementia risk

A preprint, not yet reviewed by other scientists, published October 9, 2026, analyzes 13,879 participants in the U.S. Health and Retirement Study, grouping transitions to retirement between ages 51 and 75 into ten trajectories. The authors report that retiring earlier or later from full-time work was not linked to dementia risk, while sustained part-time work was associated with lower odds of dementia (odds ratio 0.62) and prolonged disability with higher odds (odds ratio 1.53). These are associations, and the authors say gradual, flexible transitions may benefit brain health.

Published
Oct 9, 2026
DOI 10.64898/2026.10.07.26364998

Money, taxes and banking

Preprint, not peer-reviewedarXiv

Model links regulators' job prospects to risk at regulated firms

A preprint, not yet reviewed by other scientists, published October 8, 2026, models a regulator who designs policy signals while holding an implicit option to leave for the regulated firm or its advisers. The authors argue this option can delay oversight until firms cross a leverage-vega warning threshold, and report that limits on post-employment work affect post-agency pay in federal payroll data. The paper uses Lehman Brothers, Silicon Valley Bank and Signature Bank as historical illustrations and does not predict collapse dates.

Published
Oct 8, 2026
Preprint, not peer-reviewedNBER

Paper asks whether hidden charges in advertising auctions can be detected

A working paper, not yet peer-reviewed and published October 8, 2026, examines a Federal Trade Commission allegation that Amazon's advertising auctions, described as second-price, used soft reserves that charged winning advertisers up to their bids. The authors find that if advertisers see only win rates and expected charges, a soft reserve is indistinguishable from a second-price auction at any fixed bid, while flagged charges would expose it quickly.

Published
Oct 8, 2026

Phones, internet and tech

Peer-reviewed studyPNAS

New model predicts toxicity of endocrine-disrupting chemicals

A peer-reviewed study published October 5, 2026, describes a deep learning model that predicts toxic effects of chemicals from their molecular structure, with a focus on endocrine-disrupting chemicals. The authors say the model outperforms existing structure-based methods in external validations and is intended to support multi-endpoint toxicity assessment and regulatory decision-making.

Published
Oct 5, 2026
DOI 10.1073/pnas.2608919123
AnnouncementOpenAI

OpenAI says it is training AI agents on contracting work with Ironclad

An announcement from OpenAI, published October 6, 2026, says it and Ironclad are training and evaluating artificial intelligence (AI) agents on complex contracting workflows, to advance computer use for professional work. Because it is OpenAI's own account, it reports what the company says it is doing rather than independently verified results. The abstract describes the work and does not give outcomes.

Published
Oct 6, 2026
AnnouncementOpenAI

OpenAI says it disrupted two AI-enabled influence operations

An announcement from OpenAI, published October 8, 2026, says the company disrupted two influence operations that used artificial intelligence (AI) to run false-front journalists and a think tank spreading geopolitical messages. Because it is OpenAI's own account, it describes what the company reports finding and stopping rather than independently verified details.

Published
Oct 8, 2026

Science and research

Preprint, not peer-reviewedChemRxiv

Lab study reports brighter scintillator material for X-ray imaging

A preprint, not yet reviewed by other scientists, published October 6, 2026, reports a lanthanide complex scintillator, a material that emits light when hit by radiation. The authors report a light output of 134,400 photons per MeV in powder form and 180,000 in single-crystal form, which they describe as unprecedented. In an imaging test, they say it enabled at least a fivefold reduction in irradiation time compared with radiography without an intensifying screen.

Published
Oct 6, 2026
DOI 10.26434/chemrxiv.15010010/v1
Preprint, not peer-reviewedChemRxiv

Lab study reports software that reduces noise in point-of-care tests

A preprint, not yet reviewed by other scientists, published October 7, 2026, describes deep learning software that tracks the full course of a point-of-care test to correct for signal noise, shown in a lateral flow assay for xylazine. In 251 patient urine samples, the authors report 94.02% accuracy and 71.15% sensitivity, compared with 89.2% accuracy and 48.1% sensitivity for human reading, using liquid chromatography-tandem mass spectrometry as the benchmark.

Published
Oct 7, 2026
DOI 10.26434/chemrxiv.15007405/v2
Preprint, not peer-reviewedChemRxiv

Model finds location and timing can lower direct air capture costs

A preprint, not yet reviewed by other scientists, published October 8, 2026, presents a dynamic model of direct air capture, a technology for removing carbon dioxide from air, applied to Alberta, Canada, using 2024 data. The authors report that optimized locations and cycle designs reduce estimated costs by up to 20%, and that dynamic conditions favor sites in northern Alberta. Because it is a modeling study, its estimates depend on the assumptions built into the model.

Published
Oct 8, 2026
DOI 10.26434/chemrxiv.15010123/v1
Preprint, not peer-reviewedarXiv

AI method aligns mouse and human brain activity and tracks known drug efficacy

A preprint, not yet reviewed by other scientists, published October 9, 2026, describes a dual-rule contrastive learning framework that aligns mouse and human neural states by biological state rather than species. The authors report that drug-induced movement toward the human-aligned healthy state tracked known clinical efficacy retrospectively across ten model-drug combinations, and that the framework linked Fmr1-knockout mice with human 16p11.2 copy-number variant carriers. Because the tracking looks back at known outcomes, it does not show that the method predicts new results.

Published
Oct 9, 2026
Preprint, not peer-reviewedarXiv

Theory says one 'buffer' car can boost traffic flow and damp stop-and-go waves

A preprint, not yet reviewed by other scientists, published October 9, 2026, derives mathematically that when connected vehicles take distinct roles, throughput is maximized when one designated buffer vehicle keeps a larger headway, letting the rest form a tightly spaced platoon. The authors confirm this with numerical spectral analysis and simulations using two traffic models, and report higher flow than unbuffered traffic. The work is theoretical and simulation-based, not a field test.

Published
Oct 9, 2026
Peer-reviewed studyPNAS

Model finds post-infection effects could shift vaccination incentives

A peer-reviewed study published October 9, 2026, uses mathematical models to examine how morbidity that lasts after infection changes the management of vaccination and other interventions. The authors report that long-term nonpharmaceutical interventions can reduce post-acute burden, and that post-infection costs can substantially shift societal incentives toward elimination. These are model results, so they show how incentives could change rather than measuring actual costs.

Published
Oct 9, 2026
DOI 10.1073/pnas.2609982123
Preprint, not peer-reviewedChemRxiv

Study finds waste tipping fees can support hydrothermal liquefaction in some cases

A preprint, not yet reviewed by other scientists, published October 9, 2026, models hydrothermal liquefaction (HTL), a process that converts wet organic waste into fuels and bioproducts, combining 402 literature experiments with process, cost and life-cycle analyses. The authors report median internal rates of return (IRR) up to 35.8% for decentralized biobinder systems, compared with up to 8.0% for decentralized sustainable aviation fuel (SAF) systems. They say existing tipping fees can support deployment in some cases, and higher fees or incentives can widen viability.

Published
Oct 9, 2026
DOI 10.26434/chemrxiv.15010134/v1
Preprint, not peer-reviewedChemRxiv

Lab study tests hydrogel microspheres to slow cooling in geothermal reservoirs

A preprint, not yet reviewed by other scientists, published October 9, 2026, describes temperature-responsive hydrogel microspheres that could redirect flow in geothermal reservoirs away from cooled short-circuit channels. The authors report that highly idealized simulations suggest a thermal lifetime improvement by a factor of at least 24 to 59, and a laboratory experiment showing the microgels clog cooled channels and divert flow into hotter regions, which they describe as a proof of concept.

Published
Oct 9, 2026
DOI 10.26434/chemrxiv.15010139/v1
Preprint, not peer-reviewedChemRxiv

Lab study finds silver layers of a few micrometers best for metal battery anodes

A preprint, not yet reviewed by other scientists, published October 9, 2026, tests silver alloying interlayers on zinc metal anodes built from particles of 100 nm, a few μm and 100 μm. The authors report that layers of few-μm particles gave the highest plating and stripping reversibility, and say this challenges the assumption that nanostructured layers are inherently better.

Published
Oct 9, 2026
DOI 10.26434/chemrxiv.15010155/v1
Preprint, not peer-reviewedChemRxiv

Flexible, ultra-lightweight triple-junction solar cell reaches 24.1% efficiency

A preprint, not yet reviewed by other scientists, published October 9, 2026, describes a flexible solar cell with two perovskite layers and one organic layer on a 10 μm polyethylene terephthalate substrate. The authors report a power conversion efficiency of 24.1%, a stabilized efficiency of 24.6% and 11.2 W/g of power per weight, and say it could suit aerospace, unmanned aerial vehicles, wearable electronics and portable power.

Published
Oct 9, 2026
DOI 10.26434/chemrxiv.15010188/v1
Preprint, not peer-reviewedbioRxiv

Lab-designed protein reduces brain damage by over 50% in mouse stroke model

A preprint, not yet reviewed by other scientists, published October 9, 2026, describes Denasin1, a miniprotein designed by computer to block the human acid-sensing ion channel 1a (hASIC1a), which causes neuronal death during ischaemic stroke. The authors report near-complete inhibition at nanomolar potency and a reduction in infarct volume (the size of damaged tissue) of more than 50% in a murine model of ischaemic stroke. The work is in cells and mice, not people.

Published
Oct 9, 2026
DOI 10.64898/2026.10.04.755611
Preprint, not peer-reviewedbioRxiv

Drug screen identifies four compounds that inhibit dengue virus in lab models

A preprint, not yet reviewed by other scientists, published October 9, 2026, reports a high-content screen of 960 compounds from a drug repurposing library, which identified four concentration-dependent inhibitors of dengue virus. The most potent, LY411575, a gamma secretase inhibitor, had an IC of 72 nM, and the authors say time-of-addition experiments suggest it acts before late-stage infection.

Published
Oct 9, 2026
DOI 10.64898/2026.10.06.757061
Preprint, not peer-reviewedbioRxiv

Stiffer surroundings boost growth-signal activity in cells, lab study finds

A preprint, not yet reviewed by other scientists, published October 9, 2026, reports that a stiffer extracellular matrix, the material around cells, potentiates signaling by the epidermal growth factor receptor (EGFR) from single molecules up to spheroids and tissues. The authors say integrin adhesions reshape the membrane to form signaling hotspots, and suggest this could help explain why some tyrosine kinase inhibitors lose effect in tumors. The link to clinical resistance is a suggestion, not a tested finding.

Published
Oct 9, 2026
DOI 10.64898/2026.10.06.757133
Preprint, not peer-reviewedbioRxiv

Red blood cells hold tumor DNA, challenging plasma-focused liquid biopsy

A preprint, not yet reviewed by other scientists, published October 9, 2026, reports that red blood cells bind tumor-derived deoxyribonucleic acid (DNA) on their surface, forming a circulating pool. In mice with lung cancer xenografts this bound tumor DNA tracked tumor burden, and in patients with lung cancer most detected mutant tumor DNA was on red cells rather than in plasma. The authors say this challenges the plasma-centric approach to liquid biopsy.

Published
Oct 9, 2026
DOI 10.64898/2026.10.07.755430
Preprint, not peer-reviewedbioRxiv

Enzyme breaks down polyethylene, polypropylene and polystyrene in lab tests

A preprint, not yet reviewed by other scientists, published October 9, 2026, reports crystal structures of a cysteine-dependent hydrolase (CsdH) from Rhodococcus opacus in complex with polyethylene, polypropylene, polystyrene and styrene. The authors show the enzyme degrades these homopolymers into smaller products, with polyethylene degraded most, and say the work lays a foundation for enzyme engineering against microplastic pollution.

Published
Oct 9, 2026
DOI 10.64898/2026.10.07.757487
Preprint, not peer-reviewedbioRxiv

Modified RNA nanostructures silence up to four genes at once in tests

A preprint, not yet reviewed by other scientists, published October 9, 2026, describes fully chemically modified RNA nanostructures built entirely from stabilized therapeutic nucleic acids, which the authors say can deliver small interfering RNA (siRNA) to heart and muscle without a separate vehicle. The authors report sustained silencing of up to four genes from one structure, and that larger structures improve distribution to the central nervous system after cerebrospinal fluid administration.

Published
Oct 9, 2026
DOI 10.64898/2026.10.08.757482
Preprint, not peer-reviewedbioRxiv

Chronic nanoplastic exposure harms human kidney cells in lab study

A preprint, not yet reviewed by other scientists, published October 9, 2026, reports 12 days of continuous laboratory exposure of human kidney proximal tubule cells to 20 nm or 100 nm carboxylated polystyrene nanoplastics. The authors report that 20 nm particles caused progressive loss of viability and extensive gene dysregulation, while 100 nm particles had minimal effect, and they identify ANGPTL4 as a candidate early marker of kidney stress.

Published
Oct 9, 2026
DOI 10.64898/2026.10.08.757574
Preprint, not peer-reviewedbioRxiv

Carbonic anhydrase inhibitor improves heart function in Alzheimer's mouse model

A preprint, not yet reviewed by other scientists, published October 9, 2026, reports that long-term treatment of Tg2576 mice, a model of Alzheimer disease, with acetazolamide (ATZ), a carbonic anhydrase inhibitor, reduced cardiac amyloid-beta and restored heart function in 13-month-old mice. The authors also report that inhibition in human cardiomyocytes preserved brain-derived neurotrophic factor (BDNF) signaling against amyloid-beta oligomers. The work is in mice and cultured cells, not people.

Published
Oct 9, 2026
DOI 10.64898/2026.10.08.757731
AnnouncementPew Research Center

About half of U.S. adults never use chatbots, Pew finds

Pew Research Center reports, in an announcement published October 9, 2026, that about half of U.S. adults never use chatbots, and that most non-users cite disinterest, privacy or accuracy concerns. It summarizes Pew's own survey findings, so it reports what Pew says rather than independent verification.

Published
Oct 9, 2026
AnnouncementPew Research Center

Pew digest reports social media spreads rumors that harm democracy

Pew Research Center's digest of its worldwide public opinion surveys, published October 9, 2026, cites a Reuters report that social media harms democracy by spreading rumors. The same digest says most people think artificial intelligence (AI) will cut more jobs than it creates, and that Indians feel AI will widen the rich-poor gap. As a digest of other coverage, it gives the findings without survey methods.

Published
Oct 9, 2026